Journal of Integrative Medicine ›› 2016, Vol. 14 ›› Issue (1): 1-4.doi: 10.1016/S2095-4964(16)60242-X
• Commentary • Next Articles
MahsaJalilia, ZahraBazib
, AzitaHekmatdoosta
| 1 Cao Y.Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. 2 Cheung WW, Mao P.Recent advances in obesity: genetics and beyond. 3 Ali AT, Crowther NJ.Factors predisposing to obesity: a review of the literature. 4 Kandasamy AD, Sung MM, Boisvenue JJ, Barr AJ, Dyck JR.Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. 5 Kopelman P.Health risks associated with overweight and obesity. 6 Bray GA, Tartaglia LA.Medicinal strategies in the treatment of obesity. 7 Irving BA, Still CD, Argyropoulos G.Does IRISIN have a BRITE future as a therapeutic agent in humans? 8 Wang F, Wu M, Liu W, Shen Q, Sun H, Chen S.Expression, purification, and lipolytic activity of recombinant human serum albumin fusion proteins with one domain of human growth hormone in Pichia pastoris. Biotechnol Appl Biochem. 2013; 60(4): 405-411. 9 Wanarska M, Kur J.A method for the production of D-tagatose using a recombinant 10 Contreras C, Gonzalez F, Fernø J, Diéguez C, Rahmouni K, Nogueiras R, López M.The brain and brown fat. 11 du Plessis L, Rose SH, van Zyl WH. Exploring improved endoglucanase expression in Saccharomyces cerevisiae strains. Appl Microbiol Biotechnol. 2010; 86(5): 1503-1511. 12 Sun X, Sun H, Ge R, Richter M, Woodworth RC, Mason AB, He QY.The low pKa value of iron-binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin. FEBS Lett. 2004; 573(1-3): 181-185. 13 Moslehi-Jenabian S, Lindegaard L, Jespersen L.Beneficial effects of probiotic and food borne yeasts on human health. Nutrients. 2010; 2(4): 449-473. 14 Ortuño J, Cuesta A, Rodríguez A, Esteban MA, Meseguer J.Oral administration of yeast, Saccharomyces cerevisiae, enhances the cellular innate immune response of gilthead seabream (Sparus aurata L.). Vet Immunol Immunopathol. 2002; 85(1-2): 41-50. 15 D’Silva I. Recombinant technology and probiotics. Int [J] Eng Technol. 2011; 3(4): 288-293. 16 Castillo-Quan JI.From white to brown fat through the PGC- 1α-dependent myokine irisin: implications for diabetes and obesity. Dis Model Mech. 2012; 5(3): 293-295. 17 Mahajan RD, Patra SK.Irisin, a novel myokine responsible for exercise induced browning of white adipose tissue. Indian [J] Clin Biochem. 2013; 28(1): 102-103. 18 Bai Y, Ann DK, Shen WC.Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci U S A. 2005; 102(20): 7292-7296. 19 Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, Lebreton C, Ménard S, Candalh C, Ben-Khalifa K, Dugave C, Tamouza H, van Niel G, Bouhnik Y, Lamarque D, Chaussade S, Malamut G, Cellier C, Cerf-Bensussan N, Monteiro RC, Heyman M. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. [J] Exp Med. 2008; 205(1): 143-154. 20 Xia CQ, Wang J, Shen WC.Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. [J] Pharmacol Exp Ther. 2000; 295(2): 594-600. 21 Cregg JM, Tolstorukov I, Kusari A, Sunga J, Madden K, Chappell T.Expression in the yeast Pichia pastoris. Methods Enzymol. 2009; 463: 169-189. 22 Griffiths WJ, Cox TM.Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TfR2) in intestinal tissue and cells. J Histochem Cytochem. 2003; 51(5): 613-624. 23 Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerbäck S, Schrauwen P, Spiegelman BM. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012; 150(2): 366-376. |
|